The lungs' airways are affected by the chronic inflammatory condition known as asthma. Variable and recurrent symptoms, reversible airflow blockage, and readily caused bronchospasms are its distinguishing features. Episodes of wheezing, coughing, chest tightness, and shortness of breath are among the symptoms. These might happen several times per day or several times per week. Depending on the individual, asthma symptoms may get worse at night or after physical activity. It is believed that a mix of hereditary and environmental factors contribute to asthma. Exposure to allergies and air pollution are environmental variables. Beta blockers and aspirin are two more probable causes. The pattern of symptoms, treatment response over time, and spirometry lung function testing are often used to make a diagnosis. The frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate are used to categorise asthma. It can also be categorised as atopic or non-atopic, where atopy denotes a propensity for a type 1 hypersensitive reaction to occur. Although asthma cannot be cured, it may be managed. By avoiding triggers like allergens and respiratory irritants, symptoms can be avoided, and they can be reduced with the use of inhaled corticosteroids. If asthma symptoms are still not under control, long-acting beta agonists (LABA) or antileukotriene medications may be administered in addition to inhaled corticosteroids. An oral corticosteroid plus an inhaled short-acting beta-2 agonist, such as salbutamol, are typically used to treat symptoms that are rapidly getting worse. When the situation is really bad, intravenous corticosteroids, magnesium sulphate, and hospitalization may be required.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia